| Secondary Myelodysplastic Syndrome studied in …STUDIED_INderived33 of 33show fewer |
|---|
| → studied in | NCT03630991Phase 1 · recruiting Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890329Phase 1 · active not recruiting Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01885689Phase 2 · active not recruiting Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04726241Phase 1/Phase 2 · recruiting The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550442Phase 1/Phase 2 · terminated Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05146739Phase 1 · active not recruiting Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292664Phase 1 · recruiting Venetoclax Basket Trial for High Risk Hematologic Malignancies · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316701Phase 3 · active not recruiting Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04160052Phase 1/Phase 2 · terminated Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357565Phase 2 · completed Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333486Phase 2 · terminated Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02658487Phase 2 · completed Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01812252Phase 2 · completed Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128359Phase 2 · completed High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01823198Phase 1/Phase 2 · completed Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03272633early Phase 1 · terminated Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960646Phase 1 · completed Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02553941Phase 1 · completed Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02485535Phase 1 · completed Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01619761Phase 1 · unknown NK Cells in Cord Blood Transplantation · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Myelodysplastic Syndrome Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101179Phase 1 · completed MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01757639Phase 1 · completed Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00351975Phase 1 · completed Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132586Phase 1 · completed Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00145613Phase 2 · completed Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies · condition mapped ALIAS · 33 trials mapped (9 active) | — | — | Secondary Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |